{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "market": "us_market", "esgPopulated": false, "marketState": "PRE", "regularMarketChangePercent": 11.881193, "regularMarketPrice": 3.39, "exchange": "NCM", "shortName": "Acurx Pharmaceuticals, Inc.", "longName": "Acurx Pharmaceuticals, Inc.", "messageBoardId": "finmb_558025934", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": 0.36000013, "regularMarketTime": 1684180792, "regularMarketDayHigh": 3.39, "regularMarketDayRange": "3.09 - 3.39", "regularMarketDayLow": 3.09, "regularMarketVolume": 14310, "regularMarketPreviousClose": 3.03, "bid": 0.0, "ask": 0.0, "bidSize": 10, "askSize": 9, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 3.09, "averageDailyVolume3Month": 31361, "averageDailyVolume10Day": 28950, "fiftyTwoWeekLowChange": 1.0600002, "fiftyTwoWeekLowChangePercent": 0.45493573, "fiftyTwoWeekRange": "2.33 - 4.85", "fiftyTwoWeekHighChange": -1.4599998, "fiftyTwoWeekHighChangePercent": -0.3010309, "fiftyTwoWeekLow": 2.33, "fiftyTwoWeekHigh": 4.85, "firstTradeDateMilliseconds": 1624627800000, "priceHint": 4, "earningsTimestamp": 1683892800, "earningsTimestampStart": 1692016200, "earningsTimestampEnd": 1692361800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.02, "epsForward": -1.14, "epsCurrentYear": -0.95, "priceEpsCurrentYear": -3.5684211, "sharesOutstanding": 11671800, "bookValue": 0.629, "fiftyDayAverage": 3.2322, "fiftyDayAverageChange": 0.1578002, "fiftyDayAverageChangePercent": 0.0488213, "twoHundredDayAverage": 3.48706, "twoHundredDayAverageChange": -0.097059965, "twoHundredDayAverageChangePercent": -0.027834326, "marketCap": 43354372, "forwardPE": -2.9736843, "priceToBook": 5.3895073, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-25", "displayName": "Acurx Pharmaceuticals", "symbol": "ACXP"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "259 Liberty Avenue", "city": "Staten Island", "state": "NY", "zip": "10305", "country": "United States", "phone": "917-533-1469", "website": "https://www.acurxpharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase IIa clinical trial to treat patients with clostridium difficile infections. It is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia. The company was incorporated in 2017 and is headquartered in Staten Island, New York.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert J. DeLuccia", "age": 76, "title": "Co-Founder & Exec. Chairman", "yearBorn": 1946, "fiscalYear": 2022, "totalPay": {"raw": 677186, "fmt": "677.19k", "longFmt": "677,186"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. David P. Luci CPA, CPA, Esq., J.D.", "age": 55, "title": "Corp. Sec., Co-Founder, Pres, CEO & Director", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": {"raw": 655000, "fmt": "655k", "longFmt": "655,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Robert G. Shawah CPA, CPA", "age": 55, "title": "Co-Founder & CFO", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": {"raw": 375000, "fmt": "375k", "longFmt": "375,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}